Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma

To study antitumor and antimetastatic activities of antitumor vaccine (ATV) prepared from cisplatin (CP) sensitive and resistant strains of Lewis lung carcinoma (LLC). Methods: The inhibition of tumor growth, and the mean survival time of the tumor-bearing animals, the number and the volume of metas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2009
Hauptverfasser: Potebnya, G.P., Voeykova, I.M., Lisovenko, G.S., Cheremshenko, N.L., Todor, I.M., Yudina, O.Yu., Kovtonyuk, O.V., Chekhun, V.F.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2009
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/138140
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma / G.P. Potebnya, I.M. Voeykova, G.S. Lisovenko, N.L. Cheremshenko, I.M. Todor, O.Yu. Yudina, O.V. Kovtonyuk, V.F. Chekhun // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 226-230. — Бібліогр.: 36 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-138140
record_format dspace
spelling Potebnya, G.P.
Voeykova, I.M.
Lisovenko, G.S.
Cheremshenko, N.L.
Todor, I.M.
Yudina, O.Yu.
Kovtonyuk, O.V.
Chekhun, V.F.
2018-06-18T09:44:42Z
2018-06-18T09:44:42Z
2009
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma / G.P. Potebnya, I.M. Voeykova, G.S. Lisovenko, N.L. Cheremshenko, I.M. Todor, O.Yu. Yudina, O.V. Kovtonyuk, V.F. Chekhun // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 226-230. — Бібліогр.: 36 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/138140
To study antitumor and antimetastatic activities of antitumor vaccine (ATV) prepared from cisplatin (CP) sensitive and resistant strains of Lewis lung carcinoma (LLC). Methods: The inhibition of tumor growth, and the mean survival time of the tumor-bearing animals, the number and the volume of metastases were measured as the indices of ATV efficacy. The activity of cytotoxic T-lymphocytes and natural killer cells, peritoneal macrophages (Mph), the level of tumor necrosis factor and the total proteolytic activity of blood plasma (PA) were assessed. Results: ATV from CP resistant LLC prepared using cytolectin (CL) of В. subtilis В-7025 significantly inhibited growth of CP resistant tumors (by 52%) and increased mean survival time (MST) of animals (by 44.6%). The index of metastasis inhibition for ATV prepared from CP sensitive or resistant LLC was 154.5% and 227.0%, respectively. In all vaccine-treated animals, Mph activity was shown to be significantly increased. In spite of high antitumor and antimetastatic effects of ATV prepared from CP resistant LLC, PA in plasma of animals inoculated with CP resistant LLC was increased significantly upon vaccine administration.
The study was performed within the frames of the project “Peculiarities of oncogenome functioning” (№ 0102U003228) with the financial support of target scientific program of NAS of Ukraine “Physiologicalbiochemical and molecular-genetic basis of live systems functioning and development of principles of their control”.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
spellingShingle Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
Potebnya, G.P.
Voeykova, I.M.
Lisovenko, G.S.
Cheremshenko, N.L.
Todor, I.M.
Yudina, O.Yu.
Kovtonyuk, O.V.
Chekhun, V.F.
Original contributions
title_short Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
title_full Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
title_fullStr Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
title_full_unstemmed Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
title_sort antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
author Potebnya, G.P.
Voeykova, I.M.
Lisovenko, G.S.
Cheremshenko, N.L.
Todor, I.M.
Yudina, O.Yu.
Kovtonyuk, O.V.
Chekhun, V.F.
author_facet Potebnya, G.P.
Voeykova, I.M.
Lisovenko, G.S.
Cheremshenko, N.L.
Todor, I.M.
Yudina, O.Yu.
Kovtonyuk, O.V.
Chekhun, V.F.
topic Original contributions
topic_facet Original contributions
publishDate 2009
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description To study antitumor and antimetastatic activities of antitumor vaccine (ATV) prepared from cisplatin (CP) sensitive and resistant strains of Lewis lung carcinoma (LLC). Methods: The inhibition of tumor growth, and the mean survival time of the tumor-bearing animals, the number and the volume of metastases were measured as the indices of ATV efficacy. The activity of cytotoxic T-lymphocytes and natural killer cells, peritoneal macrophages (Mph), the level of tumor necrosis factor and the total proteolytic activity of blood plasma (PA) were assessed. Results: ATV from CP resistant LLC prepared using cytolectin (CL) of В. subtilis В-7025 significantly inhibited growth of CP resistant tumors (by 52%) and increased mean survival time (MST) of animals (by 44.6%). The index of metastasis inhibition for ATV prepared from CP sensitive or resistant LLC was 154.5% and 227.0%, respectively. In all vaccine-treated animals, Mph activity was shown to be significantly increased. In spite of high antitumor and antimetastatic effects of ATV prepared from CP resistant LLC, PA in plasma of animals inoculated with CP resistant LLC was increased significantly upon vaccine administration.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/138140
citation_txt Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma / G.P. Potebnya, I.M. Voeykova, G.S. Lisovenko, N.L. Cheremshenko, I.M. Todor, O.Yu. Yudina, O.V. Kovtonyuk, V.F. Chekhun // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 226-230. — Бібліогр.: 36 назв. — англ.
work_keys_str_mv AT potebnyagp antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
AT voeykovaim antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
AT lisovenkogs antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
AT cheremshenkonl antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
AT todorim antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
AT yudinaoyu antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
AT kovtonyukov antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
AT chekhunvf antitumorandantimetastaticactivitiesofvaccinepreparedfromcisplatinresistantlewislungcarcinoma
first_indexed 2025-11-29T07:12:51Z
last_indexed 2025-11-29T07:12:51Z
_version_ 1850854629139546112